Partnership to Enhance Cancer Care in Tunisia
The Salah Azaïz Institute has signed a partnership with Gustave Roussy, one of the world's leading cancer centers, on Tuesday, May 12, 2026. The agreement aims to strengthen the management of rare and complex cancers in Tunisia between 2026 and 2029.
Objectives of the Partnership
This convention was concluded as part of the Ministry of Health's efforts to modernize the national cancer control system and improve the quality of care, medical training, and scientific research. According to the ministry, this partnership provides for enhanced cooperation between Tunisian and French teams in several areas, including:
- Diagnosis and treatment of complex cancers
- Development of clinical research
- Training of medical teams
- Use of advanced technologies such as molecular biology and precision medicine
Key Provisions of the Agreement
The agreement also provides for an exchange of expertise between the two institutions and support for multidisciplinary meetings to improve the patient's journey, from diagnosis to medical follow-up. The Minister of Health stated that this convention represents a "concrete step" to enable Tunisian patients to access advanced expertise and techniques without having to resort to foreign care as the only option for complex cases.
Expected Outcomes
This partnership is expected to have a significant impact on the management of rare and complex cancers in Tunisia, providing patients with access to world-class care and expertise. By strengthening cooperation between Tunisian and French medical teams, the agreement aims to improve patient outcomes and enhance the overall quality of cancer care in the country.
